Antimicrobials Market

Antimicrobials Market

  • HC-6347
  • 4.8 Rating
  • 209 Pages
  • Upcoming
  • 87 Reviews
  • Docx PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

Antimicrobials Market Outlook 2032

The global antimicrobials market size was USD XX Million in 2023 and is projected to reach USD XX Million by 2032, expanding at a CAGR of XX% during 2024–2032. The market growth is attributed to the rising occurrence of bacterial ailments such as tuberculosis, respiratory infections, urinary tract infections (UTIs), skin infections across the globe.

Antimicrobials effectively safeguard humans against infectious diseases. These agents function by either eradicating or impeding the growth of microorganisms, which encompass bacteria, viruses, and protozoans as well as fungi such as mold and mildew. The requirement for antimicrobial additives is surging, particularly in the healthcare and packaging sectors, which attributed to its increased demand for addressing the COVID-19 pandemic on a global scale. The growing prevalence of infectious diseases, fueled by factors such as population growth, urbanization, and antimicrobial resistance, is the major driving factor in the market during the projected timeframe.

Antimicrobials Market Outlook

Impact of Artificial Intelligence (AI) on the Antimicrobials Market

Integration of artificial intelligence (AI) technologies has a high impact on addressing the challenges of antimicrobial resistance and helps in improving patient outcomes. Diagnostic tools with integration of AI analyze genomic microbial data to predict susceptibility to antimicrobial agents. This provides healthcare professionals tailored treatment regimens for individual patients, improving outcomes and reducing the risk of adverse effects. Furthermore, predictive analytics based on AI, analyzes diverse data sources, containing environmental factors, media trends, and clinical records to detect and forecast infectious disease outbreaks. It helps with timely interventions containing spread of pathogens and minimize the impact on public health.

Antimicrobials Market Dynamics

Antimicrobials Market Dynamics


Major Drivers

Increasing prevalence of infectious diseases, with growing incidences of bacterial, fungal, and viral infections globally, drives the market. The growing awareness among healthcare professionals and consumers about the importance of infection prevention fuels the demand for products. Public health awareness about the risk associated with harmful infectious disease and interventions in reducing transmission are the major growth factors during the forecast period.

Existing Restraints

Rising antimicrobial resistant pathogens pose a major challenge for the antimicrobials market. Microbes evolve to resist the effect of drugs and effectiveness of existing treatment diminishes, leading to prolonged illness, increased healthcare costs, and high mortality rates. Antimicrobials necessitate the development of new antimicrobial agents, which is costly and time consuming. Furthermore, low return on investment for new drug targeting rare infectious diseases faces challenges in the antimicrobials market.

Emerging Opportunities

Advances in antimicrobials technologies containing the development of new drug formulations, antimicrobial coatings, and medical devices offer growth opportunities for the market players. These technologies offer improved efficacy, safety, and durability as compared to conventional antimicrobial products. Moreover, such products find application in various industries, including food & beverages, packaging, textiles, and personal care products. The expansion of these industries and the increasing consumer demand for antimicrobial products drive the market.

Scope of the Antimicrobials Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report. 

Attributes

Details

Report Title

Antimicrobials Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2023

Historic Data

2017 -2022

Forecast Period

2024–2032

Segmentation

Type (Antibacterial, Antifungal, Antiviral, and Others), Origin (Natural, Semi-synthetic, and Synthetic), Route of Administration (Oral, Topical, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

Abott; AstraZeneca; BASF SE; Biocote; Bayer Material Science; Doeflex Vitapol; Dow Chemicals; Johnson & Johnson Private Limited; Mylan N.V; Merck & Co.; Novartis AG; GlaxoSmithKline Plc; F. Hoffmann-La Roche Ltd; Zydus Cadila;

Antimicrobials Market Segment Analysis

Type Analysis

Based on type, the antimicrobials market is segregated into antibacterial, antifungal, antiviral, and others. The antibacterial segment holds a large market share, due to the increasing prevalence of bacterial infections and growing demand for effective treatments. The demand for antibacterial agents is increasing, due to the need for new treatment options for multidrug resistance infections. The attention and demand for antiviral agents is increasing, due to the emergence of global pandemic.

The market shifts rapidly in response to changing epidemiological trends, advancements in drug discovery & development, and regulatory considerations. Antibacterial drugs are widely prescribed for treating bacterial infections ranging from common respiratory tract infections to life-threatening conditions.

The antiviral segment is expected to expand significantly, due to the increasing prevalence of viral infections such as HIV, Herpes, and Hepatitis. Antiviral agents treat viral infections affecting different organ systems. These drugs employ various therapeutics approaches to combat viral infections. The demand for antiviral agents varies depending on prevalence of specific viral infections, healthcare infrastructure, access to healthcare, and regulatory policies. The market is influenced by public health emergencies, vaccination programs, and antiviral stockpiling initiatives.

Antimicrobials Market Type

Origin Analysis

Based on origin, the antimicrobial market is fragmented into natural, semi-synthetic, and synthetic. The synthetic segment is expected to hold a large market share in the coming years, due to the increasing demand for synthetic microbes, derived from chemical compounds, to kill microorganisms. These compounds are developed through medicinal chemistry approaches to optimize antimicrobial activity. The dominance is attributed to their versatility, ease of manufacturing, and efficacy, allowing for the development of a wide range of antimicrobials products.

The natural segment is anticipated to be a expand substantially, owing to the increasing demand for natural antimicrobials derived from plants, animals, and minerals. These compounds have been used in traditional medicines and as antimicrobial agents in food preservatives and personal care. They are derived from plant extract, microbial metabolites, marine organisms, and other natural sources.

Route of Administration Analysis

On the basis of route of administration, the antimicrobial market is characterized by oral, topical, parenteral, and others. The oral segment is expected to dominate the market during the projected timeframe. It involves the ingestion of antimicrobial drugs to treat a wide range of infections, including respiratory tract infections and gastrointestinal infections. Oral antimicrobials offer advantages, including convenience, cost-effective, and patient compliance.

The topical segment is anticipated to expand at a moderate rate in the coming years, due to the increasing prevalence of skin and soft tissue infections as well as the growing demand for topical antimicrobials for treating such infections. Topical antimicrobials allow for targeted delivery to agents to the site of infection, minimizing systemic exposure and reducing the risk of adverse effects.

Antimicrobials Market Administration

Distribution Channel Analysis

On the basis of distribution channel, the antimicrobials market is divided into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is expected to dominate the market during the forecast period, as they offer a wide range of antimicrobials for various types of infections and growing demand for effective treatments. These pharmacies play an important role in antimicrobial stewardship programs, aiming to optimize antimicrobial use, minimizing antimicrobial resistance, and improving patient outcomes.

The retail pharmacy has sizable market share during the forecast period, owing to the increasing availability of antimicrobial in retail pharmacies and growing trend of self-medication. These pharmacies ensure access to antimicrobial medication for patients with acute infections, chronic conditions, and preventive care needs.

Regional Outlook

In terms of region, the antimicrobials market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America anticipated to register high CAGR during the forecast period, due to the increasing prevalence of infectious diseases, healthcare expenditure, technological advancements, and antimicrobial resistance. The demand for antimicrobial products in the healthcare sector for infection prevention and control drive the market in the region.

The market continues to expand in the coming years, due to the increasing demand for treatment and growing emphasis to combat antimicrobial resistance and usage in the healthcare sector. Furthermore, public health agencies in North America implement initiatives to address antimicrobial resistance to promote prevention from infections. Educational campaigns raise awareness about the responsible antimicrobial use among healthcare providers, patients, and the general public.

Europe is projected to exhibit high growth rate during the projected period, owing to the regulatory guidelines governing the approval and marketing of antimicrobial products in compliance with EU regulations. Europe has a well-established healthcare infrastructure engaged in drug discovery and commercialization. Pharmaceutical companies invest in R&D activities for new antimicrobial agent for emerging infectious diseases. Research networks  facilitate collaboration and accelerate the translation of scientific discoveries into clinical applications.

Antimicrobials Market Region

Segments

The antimicrobials market has been segmented on the basis of

Type

  • Antibacterial
  • Antifungal
  • Antiviral
  • Others

Origin

  • Natural
  • Semi-synthetic
  • Synthetic

Route of Administration

  • Oral
  • Topical
  • Parenteral
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Abott
  • AstraZeneca
  • BASF SE
  • Biocote
  • Bayer Material Science
  • Doeflex Vitapol
  • Dow Chemicals
  • Johnson & Johnson Private Limited
  • Mylan N.V
  • Merck & Co.
  • Novartis AG
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • Zydus Cadila

Competitive Landscape

Key players competing in the global antimicrobials market are Abott; AstraZeneca; BASF SE; Biocote; Bayer Material Science; Doeflex Vitapol; Dow Chemicals; Johnson & Johnson Private Limited; Mylan N.V; Merck & Co.; Novartis AG; GlaxoSmithKline Plc; F. Hoffmann-La Roche Ltd; Zydus Cadila.
These players utilize several development strategies, including product launch, partnerships, acquisition, and geographical expansion, to increase their global presence. For instance,

  • In April 2023, Microban International collaborated with Berry Global to launch Color Scents, scented trash bags integrating antimicrobial technology. This partnership aimed to merge manufacturing expertise of Berry Global with prominent position in the market of Microban International for antimicrobial technology solutions.

  • In October 2021, Sandoz, a subsidiary of Novartis, completed the acquisition of the cephalosporin antibiotics division of GSK. Sandoz has gained ownership of three renowned products Zinnat, Zinacef, and Fortum in more than 100 countries with this acquisition. This strategic move consolidates the company’s position as a major global player in the market.

    Antimicrobials Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antimicrobials Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Antimicrobials Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Antimicrobials Market - Supply Chain
  4.5. Global Antimicrobials Market Forecast
     4.5.1. Antimicrobials Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Antimicrobials Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Antimicrobials Market Absolute $ Opportunity
5. Global Antimicrobials Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Antimicrobials Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Antimicrobials Demand Share Forecast, 2019-2026
6. North America Antimicrobials Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Antimicrobials Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Antimicrobials Demand Share Forecast, 2019-2026
7. Latin America Antimicrobials Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Antimicrobials Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Antimicrobials Demand Share Forecast, 2019-2026
8. Europe Antimicrobials Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Antimicrobials Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Antimicrobials Demand Share Forecast, 2019-2026
9. Asia Pacific Antimicrobials Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Antimicrobials Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Antimicrobials Demand Share Forecast, 2019-2026
10. Middle East & Africa Antimicrobials Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Antimicrobials Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Antimicrobials Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Antimicrobials Market: Market Share Analysis
  11.2. Antimicrobials Distributors and Customers
  11.3. Antimicrobials Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Purchase Premium Report